Ledger.Open graph →
SEC Form D · filed January 27, 2016

Pulse Therapeutics, Inc

Offering
$13.8M
Sold
$5.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ST. LOUIS, MO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Peggy Stohr · ST. LOUIS, MOExecEric Moessinger · ST. LOUIS, MODirectorSean Morris · St. Louis, MOExec · DirectorThomas Hillman · St. Louis, MODirectorPeggy Stohr · ST. LOUIS, MOExecSean Morris · ST. LOUIS, MOExec · DirectorThomas Hillman · ST. LOUIS, MODirectorEric Moessinger · ST. LOUIS, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗